11/20/2024
4:07 PM | Contineum Therapeutics (Issuer)
Lorrain Daniel S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2024
4:05 PM | Contineum Therapeutics (Subject)
Lorrain Daniel S. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2024
3:08 PM | Contineum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
3:10 PM | Contineum Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/31/2024
11:46 AM | Contineum Therapeutics (Subject)
FRANKLIN RESOURCES INC (Filed by)
| Form SCHEDULE 13G | |
08/14/2024
5:03 PM | Contineum Therapeutics (Issuer)
Huhn Stephen L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
11:46 AM | Contineum Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
|
08/14/2024
11:19 AM | Contineum Therapeutics (Filer)
| Form 8-K/A | |
06/24/2024
3:20 PM | Boyce Sarah (Reporting)
Contineum Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/24/2024
3:25 PM | Boyce Sarah (Reporting)
Contineum Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
4:43 PM | Contineum Therapeutics (Issuer)
Healy John Stephen (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/03/2024
4:46 PM | Contineum Therapeutics (Issuer)
Healy John Stephen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:53 PM | Contineum Therapeutics (Issuer)
Schimmelpennink Evert B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:54 PM | Brady Todd R. (Reporting)
Contineum Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:54 PM | Contineum Therapeutics (Issuer)
Lyons-Williams Lori (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:55 PM | Contineum Therapeutics (Issuer)
Ware Olivia C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:56 PM | Contineum Therapeutics (Issuer)
Ignelzi Troy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:56 PM | Contineum Therapeutics (Issuer)
Huhn Stephen L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:58 PM | Contineum Therapeutics (Issuer)
Lorrain Daniel S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:58 PM | Contineum Therapeutics (Issuer)
Slover Peter T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:59 PM | Contineum Therapeutics (Issuer)
Stengone Carmine N. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
6:00 PM | Contineum Therapeutics (Issuer)
Ignelzi Troy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
6:03 PM | Contineum Therapeutics (Issuer)
Ignelzi Troy A. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/15/2024
3:38 PM | Contineum Therapeutics (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G | |
04/15/2024
3:20 PM | Contineum Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G | |
04/11/2024
5:10 PM | Contineum Therapeutics (Issuer)
Versant Side Fund IV, L.P. (Reporting)
Versant Vantage I GP, L.P. (Reporting)
Versant Vantage I GP-GP, LLC (Reporting)
Versant Vantage I, L.P. (Reporting)
Versant Venture Capital IV, L.P. (Reporting)
Versant Venture Capital VI, L.P. (Reporting)
Versant Ventures IV, LLC (Reporting)
Versant Ventures VI GP, L.P. (Reporting)
Versant Ventures VI GP-GP, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
4:05 PM | Contineum Therapeutics (Issuer)
JOHNSON & JOHNSON (Reporting)
Johnson & Johnson Innovation - JJDC, Inc. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/10/2024
4:12 PM | Contineum Therapeutics (Subject)
JOHNSON & JOHNSON (Filed by)
| Form SC 13G | |
04/09/2024
3:49 PM | Contineum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/09/2024
3:47 PM | Contineum Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
04/05/2024
6:08 PM | Contineum Therapeutics (Filer)
| Form 424B4 | |
04/04/2024
11:14 PM | Contineum Therapeutics (Filer)
| Form EFFECT | |
04/04/2024
8:22 PM | Contineum Therapeutics (Issuer)
Versant Side Fund IV, L.P. (Reporting)
Versant Vantage I GP, L.P. (Reporting)
Versant Vantage I GP-GP, LLC (Reporting)
Versant Vantage I, L.P. (Reporting)
Versant Venture Capital IV, L.P. (Reporting)
Versant Venture Capital VI, L.P. (Reporting)
Versant Ventures IV, LLC (Reporting)
Versant Ventures VI GP, L.P. (Reporting)
Versant Ventures VI GP-GP, LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/04/2024
4:49 PM | Contineum Therapeutics (Issuer)
Stengone Carmine N. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/04/2024
4:51 PM | Contineum Therapeutics (Issuer)
Lorrain Daniel S. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/04/2024
4:52 PM | Contineum Therapeutics (Issuer)
Slover Peter T (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/04/2024
4:54 PM | Contineum Therapeutics (Issuer)
Huhn Stephen L. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/04/2024
4:56 PM | Brady Todd R. (Reporting)
Contineum Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/04/2024
4:58 PM | Contineum Therapeutics (Issuer)
Lyons-Williams Lori (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/04/2024
4:59 PM | Contineum Therapeutics (Issuer)
Schimmelpennink Evert B. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/04/2024
4:59 PM | Contineum Therapeutics (Issuer)
Ware Olivia C (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
This Bull Market Indicator called NVDA at $116 (Ad) Every now and again we find an investment idea so incredible we can’t help but share.
And today is one of those rare days…
Except, today we won't be giving you insight on any one particular stock…
But rather, insight on a revolutionary new stock picking indicator…
In fact, within the last year, this indicator has become famous for a multitude of reasons…
But one of the biggest was because of the buy signal it issued on October 18th, 2022.
In fact, on that very day, it said to buy NVDA at $116.37…
Anyone who did would be sitting on a tremendously large return today…
But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run… All you have to do is follow this link here |
04/04/2024
1:09 PM | Contineum Therapeutics (Filer)
| Form CERT | |
04/01/2024
7:41 AM | Contineum Therapeutics (Filer)
| Form S-1/A | |
